Ketamine One, a Canada-based health and wellness company focused on treatments for mental health, is teaming up with Cognetivity Neurosciences (OTCMKTS: CGNSF) for a collaborative study on treatments for PTSD and depression, the companies announced in a press release on Thursday.
Category Press Release
Country Canada
Companies Featured
Wellbeing Digital SciencesWellbeing Digital Sciences is a mental healthcare and wellness company with a key focus on ketamine-enhanced therapy and psychedelic medicines. It has healthcare clinics across North America that aim to offer its patients transformational experiences and heal their "physical or emotional pain" using advanced psychedelic therapy research.